Follow $TXG

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $TXG by email
NASDAQ NMS - GLOBAL MARKET · TXG
+2.70% · +$1.62 · Vol 1.6M
After hours · updated 18:32:00 ET
10X Genomics Inc

10X Genomics Inc

Life Sciences Tools & Services
$61.60
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
TXG
10X Genomics Inc
Wed Sep 2 · session closed · Markets closed · resumes Thu 9:30 ET
Upper range

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

61/ 100
Veridion Score
Upper range · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 6 of 6 factors measured · Wed Sep 2 · session closed · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is TXG moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading TXG catalysts
About 10X Genomics Inc
LABORATORY ANALYTICAL INSTRUMENTS
Listed since
2019
Employees
1K
Country
US

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$60.24
Day high
$63.49
Day low
$59.41
Previous close
$59.98
52W high
$65.12
-5.41% from high
52W low
$11.34
93% of range
Market cap
$7.8B
EPS
$-0.1800
Beta
2.51
Shares out
130.3M
Volume
1.6M
0.54× rel vol
Avg volume
3M
VWAP
$61.27
Price history computed in-house
1W
-4.14%
1M
+31.04%
3M
+83.88%
1Y
+360.73%
YTD
+277.68%
SMA 50 $49.76 · above
SMA 200 $28.47 · above
52W position 93%

TXG overview

Loading financial statements
Loading TXG Form 4 filings
Public disclosures

Congress activity in TXG

No receipt-qualified Congressional disclosure is present for TXG in the cached public ledger.

Federal contracts

TXG contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for TXG in this window.
Lobbying spend

TXG lobbying filings, year to date.

Registered lobbying filings matched to 10X Genomics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for TXG in this window.
Loading news for TXG
Analyst ratings
Sovereign unlock shows live analyst consensus for TXG.
Options
Sovereign unlock shows live options positioning for TXG.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.